Scisparc signs clinical trial agreement with yale university to conduct its phase iib trial in tourette syndrome

The addition of a u . s . site will allow scisparc to accelerate trial recruitment and further development of novel treatments for patients in need

SPRC Ratings Summary

SPRC Quant Ranking